154 related articles for article (PubMed ID: 24138308)
21. Liposomal cytarabine in advanced-stage acute lymphoblastic leukemia and aggressive lymphoma with central nervous system involvement: experience of the Polish Acute Leukemia Group.
Holowiecka-Goral A; Hołowiecki J; Giebel S; Stella-Holowiecka B; Krawczyk-Kulis M; Kos K; Lehmann-Kopydłowska A; Dudzinski M; Hałasz M; Preisner W; Cioch M; Piszcz J
Leuk Lymphoma; 2009 Mar; 50(3):478-80. PubMed ID: 19294561
[No Abstract] [Full Text] [Related]
22. [Liposomal cytarabine for the treatment of leptomeningeal dissemination of central nervous system tumours in children and adolescents].
Moreno L; García Ariza MA; Cruz O; Calvo C; Fuster JL; Salinas JA; Moscardo C; Portugal R; Merino JM; Madero L
An Pediatr (Barc); 2016 Nov; 85(5):274.e1-274.e8. PubMed ID: 27086069
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics and safety of intrathecal liposomal cytarabine in children aged <3 years.
Peyrl A; Sauermann R; Traunmueller F; Azizi AA; Gruber-Olipitz M; Gupper A; Slavc I
Clin Pharmacokinet; 2009; 48(4):265-71. PubMed ID: 19492871
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and Toxicity of Intrathecal Liposomal Cytarabine in First-line Therapy of Childhood Acute Lymphoblastic Leukemia.
Levinsen M; Harila-Saari A; Grell K; Jonsson OG; Taskinen M; Abrahamsson J; Vettenranta K; Åsberg A; Risteli J; Heldrup J; Schmiegelow K
J Pediatr Hematol Oncol; 2016 Nov; 38(8):602-609. PubMed ID: 27571129
[TBL] [Abstract][Full Text] [Related]
25. Neurological and cytological response as potential early predictors of time-to-progression and overall survival in patients with leptomeningeal carcinomatosis treated with intrathecal liposomal cytarabine: a retrospective cohort study.
Fusco JP; Castañón E; Carranza OE; Zubiri L; Martín P; Espinós J; Rodríguez J; Santisteban M; Aramendía JM; Gil-Bazo I
J Neurooncol; 2013 Dec; 115(3):429-35. PubMed ID: 24037499
[TBL] [Abstract][Full Text] [Related]
26. Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis.
Bomgaars L; Geyer JR; Franklin J; Dahl G; Park J; Winick NJ; Klenke R; Berg SL; Blaney SM
J Clin Oncol; 2004 Oct; 22(19):3916-21. PubMed ID: 15459213
[TBL] [Abstract][Full Text] [Related]
27. High-dose cytarabine-based therapy in adults with acute lymphoblastic leukemia.
Feldman EJ
Leuk Res; 2000 Mar; 24(3):189-91. PubMed ID: 10739000
[No Abstract] [Full Text] [Related]
28. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
Sancho JM; Ribera JM; Oriol A; Hernandez-Rivas JM; Rivas C; Bethencourt C; Parody R; Deben G; Bello JL; Feliu E;
Cancer; 2006 Jun; 106(12):2540-6. PubMed ID: 16700036
[TBL] [Abstract][Full Text] [Related]
29. Liposomal cytarabine for central nervous system embryonal tumors in children and young adults.
Partap S; Murphy PA; Vogel H; Barnes PD; Edwards MS; Fisher PG
J Neurooncol; 2011 Jul; 103(3):561-6. PubMed ID: 20859651
[TBL] [Abstract][Full Text] [Related]
30. Intrathecal liposomal cytarabine for prevention of meningeal disease in patients with acute lymphocytic leukemia and high-grade lymphoma.
McClune B; Buadi FK; Aslam N; Przepiorka D
Leuk Lymphoma; 2007 Sep; 48(9):1849-51. PubMed ID: 17786723
[No Abstract] [Full Text] [Related]
31. Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapy.
Aichberger KJ; Herndlhofer S; Agis H; Sperr WR; Esterbauer H; Rabitsch W; Knöbl P; Haas OA; Thalhammer R; Schwarzinger I; Sillaber C; Jäger U; Valent P
Eur J Clin Invest; 2007 Oct; 37(10):808-13. PubMed ID: 17727673
[TBL] [Abstract][Full Text] [Related]
32. [Adult acute lymphoblastic leukemia with central nervous system involvement: an overview].
Thomas X; Pavan L; Le QH
Bull Cancer; 2008; 95(7):707-15. PubMed ID: 18755650
[TBL] [Abstract][Full Text] [Related]
33. Safety and Efficacy of Liposomal Cytarabine in the Treatment of Neoplastic Meningitis.
Jahn F; Jordan K; Behlendorf T; Globig C; Schmoll HJ; Müller-Tidow C; Jordan B
Oncology; 2015; 89(3):137-42. PubMed ID: 25791073
[TBL] [Abstract][Full Text] [Related]
34. Concurrent intrathecal methotrexate and liposomal cytarabine for leptomeningeal metastasis from solid tumors: a retrospective cohort study.
Scott BJ; van Vugt VA; Rush T; Brown T; Chen CC; Carter BS; Schwab R; Fanta P; Helsten T; Bazhenova L; Parker B; Pingle S; Saria MG; Brown BD; Piccioni DE; Kesari S
J Neurooncol; 2014 Sep; 119(2):361-8. PubMed ID: 24942463
[TBL] [Abstract][Full Text] [Related]
35. Intracranial hypertension following intrathecal administration of liposomal cytarabine.
Lunskens S; Lammertijn L; Deeren D; Bergmans B; Maertens J; Vandenberghe R
J Neurol; 2011 Jan; 258(1):162-3. PubMed ID: 20706845
[No Abstract] [Full Text] [Related]
36. Neurologic complications after intrathecal liposomal cytarabine in combination with systemic polychemotherapy in primary CNS lymphoma.
Ostermann K; Pels H; Kowoll A; Kuhnhenn J; Schlegel U
J Neurooncol; 2011 Jul; 103(3):635-40. PubMed ID: 20953896
[TBL] [Abstract][Full Text] [Related]
37. [Spinal subacute combined degeneration after intrathecal chemotherapy. Report of two cases].
Cartier R L; Parra V J; Puga B; Cardemil D
Rev Med Chil; 2018 Jun; 146(6):802-807. PubMed ID: 30148913
[TBL] [Abstract][Full Text] [Related]
38. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
Pöttgen C; Stuschke M; Stüben G; Schmitz A; Schwechheimer K; Wacker HH; Rauhut F; Kleuker S; Wilhelm H; Grehl S; Fehlings T
Strahlenther Onkol; 2003 Sep; 179(9):626-32. PubMed ID: 14628129
[TBL] [Abstract][Full Text] [Related]
39. Neurologic complications of intrathecal liposomal cytarabine administered prophylactically to patients with non-Hodgkin lymphoma.
Gállego Pérez-Larraya J; Palma JA; Carmona-Iragui M; Fernández-Torrón R; Irimia P; Rodríguez-Otero P; Panizo C; Martínez-Vila E
J Neurooncol; 2011 Jul; 103(3):603-9. PubMed ID: 20953897
[TBL] [Abstract][Full Text] [Related]
40. Myelopathy due to intrathecal chemotherapy: magnetic resonance imaging findings.
Counsel P; Khangure M
Clin Radiol; 2007 Feb; 62(2):172-6. PubMed ID: 17207701
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]